Peter Feldman Highlights Hereditary Factor X Deficiency Day and the Impact of Coagadex Production at Kedrion’s BPL Site
Peter Feldman, Director of Pharmaceuticals and Healthcare at Queen’s House Consulting, shared on LinkedIn:
”On Hereditary Factor X Deficiency Day (10/10), I have been visiting Kedrion’s BPL site in Elstree, UK, meeting some of the one-in-ten-million people* who manufacture Coagadex factor X concentrate for the one-in-one-million people** living with factor X deficiency.
Great to meet friends old and new who maintain supply of this ultra-orphan drug product, purified from human blood plasma (coincidently, it is also International Plasma Awareness Week).
Sorry not to tag you all, but it would exceed my character-count allowance!
In an age where pharma companies are simultaneously celebrated for their innovation and castigated for their commercialism, it important to recognise the needs of people who live life to the max alongside their coagulation factor deficiency and the individual commitment of people across the plasma industry who strive to facilitate this.
*approximately 8 billion people on the planet and approximately 1000 people on the Elstree site = 1 in 10 million (rounded up).”
Read the full factsheet here.
Stay updated with Hemostasis Today.
-
Nov 29, 2025, 18:55Ahmad Thuaimer: Success Story – Advanced Interventional Care for DVT
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology
-
Nov 29, 2025, 16:42Vikas Dua: Heme Next 1.0 A Conference with a Difference
-
Nov 29, 2025, 16:41Hind Ali: Sources Of Error in Cell Counts
-
Nov 29, 2025, 16:40Maxime Dely: Even on a Break, You Can Give
-
Nov 29, 2025, 16:39Shrinidhi Nathany: HemeNext Brings Science, Technology, and Leadership Together